Back to search results

Sequential Therapies After Osteoanabolic Treatment

Abroad (travel likely)Recruiting

Conditions

Osteoporosis, Postmenopausal

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • 251 Airforce & VA General Hospital, Athens, Greece

    Contact: Study coordinator (Polyzois Makras, PhD) · pmakras@gmail.com · +302107463606

  • First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece

    Contact: Study coordinator (Maria P Yavropoulou, Consultant) · myavropoulou@med.uoa.gr · +30 2132060800

  • , KAT General Hospital, Athens, Greece

    Contact: Study coordinator (Symeon Tournis, PhD) · stournis@med.uoa.gr · +30 2132086000

  • 424 General Military Hospital, Thessaloniki, Greece

    Contact: Study coordinator (Athanasios D Anastasilakis, PhD) · a.anastasilakis@gmail.com · +302310381697
    Contact: Study coordinator (Stergios A Polyzos, PhD) · stergios@endo.gr · +302310455780

  • Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Milan, Italy

    Contact: Study coordinator (Cristina Eller-Vainicher) · eller.vainicher@gmail.com
    Giorgia Grassi, MD (Sub-investigator)

  • Campus Bio-Medico University, Roma, Italy

    Contact: Study coordinator (Andrea Palermo, Ass Prof) · A.Palermo@unicampus.it
    Contact: Study coordinator (Gaia Tabacco, PhD)
    Anda Naciu, PhD (Sub-investigator)
    Gaia Tabacco, PhD (Sub-investigator)

  • Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy

    Contact: Study coordinator (Luigi Gennari, prof) · gennari@unisi.it
    Contact: Study coordinator (Daniela Merlotti)
    Daniela Merlotti (Sub-investigator)

  • University-Hospital S. Maria della Misericordia, Udine, Italy

    Contact: Study coordinator (Fabio Vescini) · fabio.vescini@asufc.sanita.fvg.it
    Antonio Salcuni (Sub-investigator)
Study leads

  • Willem Lems, Prof

    Study Chair

    ECTS Clinical Action Group

View source on ClinicalTrials.gov(opens in a new tab)